Enzymatic Synthesis of Enantiopure (R)-Citronellal from Geraniol via a Short-Chain Dehydrogenase and Ene Reductase

Journal Article (2025)
Author(s)

Claudia Ferrer Carbonell (TU Delft - BT/Biocatalysis)

R. Villa (University of Murcia, TU Delft - BT/Biocatalysis)

Iris Viskaal (Student TU Delft)

Diederik J. Opperman (University of the Free State)

C.E. Paul (TU Delft - BT/Biocatalysis)

Research Group
BT/Biocatalysis
DOI related publication
https://doi.org/10.1002/adsc.202500060
More Info
expand_more
Publication Year
2025
Language
English
Research Group
BT/Biocatalysis
Reuse Rights

Other than for strictly personal use, it is not permitted to download, forward or distribute the text or part of it, without the consent of the author(s) and/or copyright holder(s), unless the work is under an open content license such as Creative Commons.

Abstract

The development of synthetic routes to produce enantiopure (R)-citronellal as a key intermediate for the synthesis of (–)-menthol and other valuable terpenoids is highly relevant in the pharmaceutical, flavor, and fragrance industries. Herein, we showcase a cascade with two consecutive biocatalytic steps performed separately using the inherent selectivity of a short-chain alcohol dehydrogenase (SDR) and an ene reductase (ERED) from the Old Yellow Enzyme (OYE) family. The first reaction involves the AaSDR1-catalyzed oxidation of relatively inexpensive geraniol in a biphasic system, providing geranial as an intermediate. The organic phase containing geranial is then extracted and transferred to the second step, where the ERED variant OYE2_Y83V catalyzes the asymmetric reduction of geranial to produce (R)-citronellal, achieving >90% conversion and >99% enantiomeric excess. The use of n-heptane in a two-liquid phase system not only facilitates substrate and product solubilization but also minimizes geranial isomerization. This biocatalytic cascade therefore enables the synthesis of enantiopure (R)-citronellal.